Metabolic studies of different fatty acids frequently require use of their radioactive esters of CoA and carnitine. However, these derivatives are not readily available even for some of the commonly used fatty acids. While procedures for synthesizing these intermediates have been described many are not suitable for synthesizing submicromole quantities of radioactive fatty acids that individual investigators often need. We describe here a procedure for doing this that is simple, does not require purified enzymes, and yields esters of both CoA and carnitine from the same incubation system.
We have found that the use of rat liver outer mitochondrial membranes (OMV) is a convenient source for these syntheses. These membranes are relatively simple to isolate, show high specific activities of acyl-CoA ligase and outer carnitine palmitoyltransferase (CPT,) [I] and have low acyl-CoA hydrolase activity. The specific activity of CPT, was 40 to 70 nmol/min/mg when assayed with palmitoyl-CoA as in [l] but with 2 mM carnitine and about three times as much when assayed with octanoyl-CoA as in [2] but with 100 mM potassium phosphate and 5 mM carnitine. Moreover, these activities have proven stable to storage when the OMV are ffpt frozen (-80°C) or lyophilized.
With (1-CJ-octanoic and -palmitic acids, under conditions we have worked out, the enzyme incubation step produces corresponding esters of CoA and carnitine in about equal proportions with combined isotopic yield of around 97 and 70 %, respectively.
We are describing below the details of the incubation and product isolation procedures optimized for obtaining CoA and carnitine esters of the above fatty acids.
In view of the broad substrate specificity of the acyl-CoA ligase and the CPTo, and the general nature of the product separation steps used, the procedures described here should allow the CoA and carnitine esters of other fatty acids also to be obtained in a like manner.
For synthesizing the CoA and carnitine esters of palmitic acid, the reaction system in 1 ml contains; 250 mM potassium phosphate, pH 7.4, 1.875 mM CoA, 5 mM ATP, mM L-carnitine, 10 mM MgC12, 1 mg BSA, 185 nmole 1-4C palmitate (10 pCi), 50 pg OMV (to start incubations). Incubations are for 90 min at 37OC with shaking.
Reactions are stopped by chilling and addition of 50 pL of 5 M HC1. Unused palmitic acid is removed by extraction with 3 ml of diethyl ether four times. The aqueous phase is extracted with 3 ml of water-saturated-butanol thrice. The combined butanol phase is washed with 2 ml of butanolsaturated-water twice and is then ftlyophilized". The residue is taken up in 2 ml of 80% (v/v) methanol, its pH is brought to 5 to 6 by 1 M KOH, then the solution is passed through DEAE Sephacel column (acetate form, 5 mm X 50 mm, equilibrated in 80 % methanol). Six ml of 80% methanol is further passed through to complete palmitoylcarnitine elution.
The palmitoyl-CoA is eluted with 9 ml of 80% methanol containing 10 mM acetic acid and 0.5 M ammonium acetate. The solvent is driven off under nitrogen and the material is lyophilized. Purity checks are by reversed phase HPLC For synthesizing octanoyl-CoA and octanoylcarnitine the incubation procedure is as above except that palmitic acid is replaced by &belled octanoic acid (0.17 pmole, 100 pCi of 1-C) and BSA is not included. After ether extractions, the pH of the aqueous phase is brought to 5 to 6 by 1 M KOH and the solution is passed through DEAE Sephacel and processed as above. The eluent in 80% methanol in this case contains octanoylcarnitine with free carnitine while the eluent having ammonium acetate has octanoyl-CoA with free CoA.
The octanoylcarnitine is separated from free carnitine by blowing off methanol under nitrogen, and then butanol extractions are carried out as described above. The final products are lyophilized. Purity is monitored by HPLC [4] .
For isolating octanoyl-CoA, the ammonium acetate eluent is lyophilized, the residue is taken up in 1.5 ml water, pH adjusted to 5 to 6 and the solution is applied on a 3 ml pre-packed C18 reverse phase column (Supelclean of Supelco; washed with water, methanol then water). The eluent is passed again through the same column three more times, then the column is washed with 2 ml of 5% acetonitrile-95% 50 mM potassium phosphate, pH 5.6. This elutes the free CoA. Octanoyl-CoA is next eluted with 5 to 6 ml of 60% acetonitrileA0X 50 mM phosphate buffer, pH 5.6. This eluent contains octanoyl-CoA of over 90% purity; virtually pure octanoyl-CoA is then obtained by reversed phase HPLC [ 3 ] .
Under the conditions described above the product yields were not noticeably affected by (a) variations in the enzyme incubation step of from 30 to 180 min. (b) variations in the quantity of OMV proteins from 6 to 100 pg; yields declined when more than about 300 pg protein was present; it was only 68% with 1 mg OMV protein and octanoate as a substrate. Use of a high salt, 250 mM potassium phosphate, at the enzyme incubation step enabled lower amounts of OMV protein to be used, minimizing contribution of interfering side reactions and gave high yields of the acyl esters.
This presumably resulted from the activating/stabilizing effect of salts on the CPT, [5] and the acyl-CoA ligase activities ( 6 1 .
We acknowledge financial support from the Medical Research Council of Canada (MT 4264) and the Quebec Heart and Stroke Foundation.
